Biotron Ltd.

Biotron Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0
Market Cap
AUD44.68 M
Shares Outstanding
595.71 M
Public Float
592.79 M

Profile

Address
56 Delhi Road
North Ryde New South Wales (NSW) 2113
Australia
Employees -
Website http://www.biotron.com.au
Updated 07/08/2019
Biotron Ltd. is a clinical stage Australian biotechnology company. It engages in developing and commercializing a novel small molecule approach that has the potential to treat a number of serious viral diseases. The company's technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus.

Financials

View All

Michelle Miller
Chief Executive Officer & Executive Director
Michael John Hoy
Independent Non-Executive Chairman